Display options
Share it on

J Thorac Dis. 2018 Jul;10:S2238-S2247. doi: 10.21037/jtd.2017.12.122.

Atypical antibody responses to influenza.

Journal of thoracic disease

Dalton Hermans, Richard J Webby, Sook-San Wong

Affiliations

  1. Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53715, USA.
  2. Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

PMID: 30116603 PMCID: PMC6072921 DOI: 10.21037/jtd.2017.12.122

Abstract

Influenza viruses undergo rapid antigenic evolution and reassortment, resulting in annual epidemics and the occasional pandemics. Exposure to influenza virus hemagglutinin (HA) and neuraminidase (NA) antigen, either through vaccination or infection, induces an antibody response able to recognize only the homologous antigenic subtype. However, atypical antibody responses recognizing non-homologous influenza subtypes have been reported during infection and vaccination. Here, we review the incidence of these phenomena in published literature and discuss the potential mechanisms underlying them.

Keywords: Influenza; antibody; heterosubtypic; neutralizing

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. PLoS One. 2010 Aug 30;5(8):e12474 - PubMed
  2. Emerg Infect Dis. 2010 Oct;16(10):1618-20 - PubMed
  3. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52 - PubMed
  4. Cell. 2016 Jul 28;166(3):609-623 - PubMed
  5. Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):941-6 - PubMed
  6. Cell. 1982 Mar;28(3):477-87 - PubMed
  7. Infect Immun. 1982 Jun;36(3):1102-8 - PubMed
  8. Science. 2011 Aug 12;333(6044):850-6 - PubMed
  9. J Infect Dis. 2006 May 1;193(9):1229-35 - PubMed
  10. Annu Rev Biochem. 1987;56:365-94 - PubMed
  11. Annu Rev Microbiol. 1983;37:529-49 - PubMed
  12. PLoS Pathog. 2013;9(10):e1003657 - PubMed
  13. Nature. 2010 Sep 30;467(7315):591-5 - PubMed
  14. Immunology. 2006 Sep;119(1):1-7 - PubMed
  15. J Clin Virol. 2015 Dec;73:108-111 - PubMed
  16. Nature. 2014 Dec 18;516(7531):418-22 - PubMed
  17. Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8 - PubMed
  18. Curr Opin Virol. 2017 Jun;24:60-69 - PubMed
  19. Science. 2012 Sep 14;337(6100):1343-8 - PubMed
  20. J Virol. 2014 Apr;88(8):4047-57 - PubMed
  21. Annu Rev Immunol. 1993;11:331-60 - PubMed
  22. Vaccine. 2007 Jun 28;25(27):5086-96 - PubMed
  23. J Virol. 2014 Mar;88(6):3432-42 - PubMed
  24. Science. 2005 Jun 24;308(5730):1906-8 - PubMed
  25. J Infect Dis. 2002 Nov 15;186(10):1490-3 - PubMed
  26. Lancet. 1981 Oct 24;2(8252):887-91 - PubMed
  27. Virology. 1994 Nov 15;205(1):17-23 - PubMed
  28. J Clin Invest. 2015 Jul 1;125(7):2631-45 - PubMed
  29. Emerg Infect Dis. 2012 Jul;18(7):1132-4 - PubMed
  30. Virology. 1997 Jun 9;232(2):345-50 - PubMed
  31. Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83 - PubMed
  32. PLoS One. 2015 May 07;10(5):e0125618 - PubMed
  33. Influenza Other Respir Viruses. 2013 Nov;7(6):1079-87 - PubMed
  34. Am J Respir Crit Care Med. 2014 Feb 15;189(4):449-62 - PubMed
  35. Cell Mol Life Sci. 2012 May;69(9):1435-45 - PubMed
  36. Nat Struct Mol Biol. 2009 Mar;16(3):265-73 - PubMed
  37. Clin Infect Dis. 2011 Apr 15;52(8):1003-9 - PubMed
  38. Emerg Infect Dis. 2014 Jan;20(1):6-12 - PubMed
  39. MBio. 2014 Mar 04;5(2):e00031-14 - PubMed
  40. Virology. 1955 Jul;1(2):176-84 - PubMed
  41. Genome Med. 2015 Nov 25;7:124 - PubMed
  42. Singapore Med J. 1970 Mar;11(1):33-7 - PubMed
  43. J Clin Virol. 2008 Feb;41(2):148-51 - PubMed
  44. Vaccine. 2007 Sep 28;25(39-40):6852-62 - PubMed
  45. N Engl J Med. 2006 Mar 30;354(13):1343-51 - PubMed
  46. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1817-28 - PubMed
  47. Front Immunol. 2012 May 08;3:87 - PubMed
  48. Protein Cell. 2010 Jan;1(1):9-13 - PubMed
  49. Immunol Today. 1995 Jul;16(7):310-3 - PubMed
  50. Cell Rep. 2015 Dec 29;13(12):2842-50 - PubMed

Publication Types

Grant support